Uses Next Generation Sequencing (NGS) to perform diagnostics on genetic diseases
Blueprint Genetics has raised €20M across 3 funding rounds from 6 investors, most recently a Series A round in Aug 2017. Based in Helsinki, Finland; founded 2012; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2017-08-03 | Series A | €14M | Creathor Venture,Inventure Oy,MedTech Innovation Partners,Pontos Group,Stanford University | View deal → |
| 2014-09-01 | Other | €3.5M | — | View deal → |
| 2014-08-01 | Seed | €2.9M | InVenture Partners | View deal → |
